Alpine Immune Sciences and Horizon Therapeutics plc Announce Exclusive License and Collaboration Agreement to Develop Novel Protein-Based Therapies for Autoimmune and Inflammatory Diseases Read more
Book to attend the Parallel Trade conference before midnight Friday 17th December and save £200 Read more
European Commission Approves Merck’s VAXNEUVANCE (Pneumococcal 15-valent Conjugate Vaccine) for Individuals 18 Years of Age and Older Read more
FDA grants Priority Review for spesolimab for the treatment of flares in patients with generalized pustular psoriasis (GPP), a rare, life-threatening skin disease Read more
Rakuten Medical Announces FDA Acceptance of an Investigational New Drug (IND) Application for RM-1995, a Conjugate of IR700 and anti-CD25 Antibody Read more
Immatics and Bristol Myers Squibb Enter Into Global Exclusive License for Immatics’ TCR Bispecific Program IMA401 Read more
Zealand Pharma Announces Seven-Year, $200 Million Financing Agreement with Oberland Capital Read more
Atea Pharmaceuticals Introduces New Strategic Clinical Development Program for AT-527 in COVID-19 Read more
Pfizer Announces Additional Phase 2/3 Study Results Confirming Robust Efficacy of Novel COVID-19 Oral Antiviral Treatment Candidate in Reducing Risk of Hospitalization or Death Read more
Biogen and TheraPanacea Announce New Collaboration with the Potential to Advance Digital Health for Personalized Medicine in Neuroscience Read more